Torrent PharmaceuticalsTORNTPHARM 
0.25%24h
Torrent Pharmaceuticals (TORNTPHARM) Stock Overview
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
TORNTPHARM Stock Information
Torrent Pharmaceuticals (TORNTPHARM) Price Chart
Torrent Pharmaceuticals Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $40.84 | N/A |
| Market Cap | $13.82B | N/A |
| Shares Outstanding | 338.45M | 0.00% |
| Employees | 13.25K | N/A |
| Shareholder Equity | 61.98B | 4.12% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | 1.11 | N/A |
| P/S Ratio | 12.26 | N/A |
| P/B Ratio | 0.22 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | 0.0024 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $1.13B | N/A |
| Earnings | $148.35M | N/A |
| EPS | 36.79 | N/A |
| Earnings Yield | 0.9009 | N/A |
| Gross Margin | 0.7012 | N/A |
| Operating Margin | 0.2261 | N/A |
| Net income margin | 0.1316 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $1.79B | N/A |
| Total Debt | $639.56M | N/A |
| Cash on Hand | $86.10M | N/A |
| Debt to Equity | 0.0169 | 18.45% |
| Cash to Debt | 0.1346 | -6.02% |
| Current Ratio | 0.9755 | -16.62% |
